Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2caaba601fd6460c7b37706d920d42e2 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2027 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2059 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-095 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-095 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 |
filingDate |
2003-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2005-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af3d9396cf1b6302e4a1ba6f34fa3696 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8df13765fbf9bd0b74bb7d1059d67616 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_69d86c0c62f7309a87557800693e3773 |
publicationDate |
2005-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-1500390-B1 |
titleOfInvention |
Pharmaceutical desmopressin composition as solid dosage form and method for manufacturing thereof |
abstract |
The present invention relates to a novel pharmaceutical composition as a solid dosage form comprising desmopressin as a therapeutically active ingredient, and to a method for manufacturing thereof. The invention relates to a pharmaceutical composition as a solid dosage form comprising desmopressin, or a pharmaceutically acceptable salt thereof, as a therapeutically active ingredient together with a pharmaceutically acceptable excipient, diluent or carrier, or mixture thereof, wherein the pharmaceutical composition is composed of a compressed granulate and contains lubricant in an amount of from 0.05 to less than 0.50 percent by weight of said pharmaceutical composition. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9220747-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9919025-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8802624-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9504647-B2 |
priorityDate |
2003-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |